Prurigo Nodularis Clinical Trials 2022

Browse 7 Prurigo Nodularis Medical Studies Across 112 Cities

4 Phase 3 Trial · 207 Prurigo Nodularis Clinics

Reviewed by Michael Gill, B. Sc.
7 Prurigo Nodularis Clinical Trials Near Me
Phoenix, AZ
Dallas, TX
Saint Joseph, MO
Athens, OH
More Trial Locations
An interactive map to display trial locations for Investigative Site US024, Investigative Site US018, Investigative Site US006, Investigative Site US023, and 109 more locations.
Top Hospitals for Prurigo Nodularis Clinical Trials
Location
Active Prurigo Nodularis Clinical Trials
All Time Trials for Prurigo Nodularis
First Recorded Prurigo Nodularis Trial
Trials
Galderma Investigational Site, Ann Arbor, Michigan
2
2
2020
Galderma Investigational Site, Saint Louis, Missouri
2
2
2020
Galderma Investigational Site, Delray Beach, Florida
2
2
2020
Galderma Investigational Site, Hollywood, Florida
2
2
2020
Galderma Investigational Site, Tampa, Florida
2
2
2020
Top Treatments for Prurigo Nodularis Clinical Trials
Treatment Name
Active Prurigo Nodularis Clinical Trials
All Time Trials for Prurigo Nodularis
First Recorded Prurigo Nodularis Trial
Trials
INCB054707
1
1
2021
vixarelimab
1
1
2019
Top Cities for Prurigo Nodularis Clinical Trials
City
Active Prurigo Nodularis Clinical Trials
Top Active Site for Prurigo Nodularis Clinical Trials
Trial List
Tampa, Florida
7
Galderma Investigational Site
New York, New York
6
Galderma Investigational Site
Miami, Florida
5
Galderma Investigational Site
Saint Joseph, Missouri
4
Galderma Investigational Site
Troy, Michigan
4
Investigative Site US017
Which phases are most popular for prurigo nodularis clinical trials?
Phase
Active Prurigo Nodularis Clinical Trials
Number of Unique Treatments
Number of Active Locations
Trial List
Phase 2 & 3
1
1
37
How many prurigo nodularis clinical trials are open to youth and / or seniors?
Age Group
Active Prurigo Nodularis Clinical Trials
Trial List
Most Recent Prurigo Nodularis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
11/4/2021
Phase 2
12/15/2020
Phase 3
Phase 3 Prurigo Nodularis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
12/15/2020
Phase 3
8/7/2018
Phase 2 & 3
Senior Friendly Prurigo Nodularis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
11/4/2021
Phase 2
12/15/2020
Phase 3
Recently Completed Studies with FDA Approved Treatments for Prurigo Nodularis
Treatment
Year
Mechanism of Action
Sponsor
Active Prurigo Nodularis Clinical Trials
Abrocitinib
2021
Abrocitinib
Johns Hopkins University
0
Moisturizers
2019
Sanofi
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: September 10th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.